Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Nabs FDA Emergency Use Authorization for Coronavirus Assay

NEW YORK – Quidel said after the close of the market on Tuesday that the US Food and Drug Administration has issued Emergency Use Authorization for the firm's Lyra SARS-CoV-2 assay for the detection of the coronavirus that causes COVID-19.

The RT-qPCR test is for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or oropharyngeal swab specimens from patients suspected of having the coronavirus.

San Diego-based Quidel noted that its Lyra product line offers PCR reagent kits that can be used by laboratories equipped with molecular testing instrumentation such as the Applied Biosystems 7500 Fast DX platforms from Thermo Fisher Scientific.

On Monday, FDA issued EUAs to Hologic and Laboratory Corporation of America, following similar authorizations to Thermo Fisher Scientific and Roche.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.